Technical and Executive Recruitment Specialists
Connect With Us  

Your career search begins here…

Submit Your CV

Send Me Job Alerts

US-headquartered generic drug manufacturer Amneal Pharmaceuticals is to create up to 300 new jobs

US-headquartered generic drug manufacturer Amneal Pharmaceuticals is to create up to 300 new jobs

US-headquartered generic drug manufacturer Amneal Pharmaceuticals is to create up to 300 new jobs in Tipperary following its acquisition of the former Johnson & Johnson plant in Cashel.

The 200,000 square foot facility was sold to Amneal by Singapore-based investment firm Solidus Private Equity. The former Johnson & Johnson plant had been vacant for four years before being acqured by Solidus earlier this year.

Amneal said the Cashel site will be dedicated to R&D and production of metered dose and dry powder inhalers as well as biosimilars .

Amneal co-chief executive Chintu Patel said the company expects to hire an estimated 250-300 employees at full build-out. From its start in 2002 as a contract drug manufacturer, Amneal has grown dramatically to its current position as the 7th largest US generics supplier by volume.

Our new Ireland facility is critical to Amneal’s long-term global growth, in Europe, the US and throughout the world,” Chintu Patel, Amneal co-CEO and co-chairman

IDA Ireland chief executive Martin Shanahan said regional development is a core part of the agency’s strategy.

“This announcement is great news for Tipperary and the whole of the South East region. That Amneal has chosen to locate in a facility that had been occupied previously is especially pleasing” 

Martin Shanahan, Chief Executive, IDA Ireland

Tags : , ,

Share:

Submit Your CV

Send in your CV today and we'll do
our best to match the most
suitable positions for you.

Send Me Job Alerts

Stay up to date with the latest jobs
entered onto our system,
emailed to your inbox.

Careerwise Recruitment



What recruitment agencies look for April 19, 2018 5 Things Recruiters Are Looking For Right Now
Great News for Cork as Rubrik's Announces 50 New Jobs April 16, 2018 Great News for Cork as Rubrik’s Announces 50 New Jobs
Accounting Recruitment Agency Cork April 11, 2018 5 Ways To Take Control Of Your Finance & Accounting Career
Job Interview Cork April 3, 2018 5 Things You Should Never Say In A Job Interview

US-headquartered generic drug manufacturer Amneal Pharmaceuticals is to create up to 300 new jobs

US-headquartered generic drug manufacturer Amneal Pharmaceuticals is to create up to 300 new jobs

US-headquartered generic drug manufacturer Amneal Pharmaceuticals is to create up to 300 new jobs in Tipperary following its acquisition of the former Johnson & Johnson plant in Cashel.

The 200,000 square foot facility was sold to Amneal by Singapore-based investment firm Solidus Private Equity. The former Johnson & Johnson plant had been vacant for four years before being acqured by Solidus earlier this year.

Amneal said the Cashel site will be dedicated to R&D and production of metered dose and dry powder inhalers as well as biosimilars .

Amneal co-chief executive Chintu Patel said the company expects to hire an estimated 250-300 employees at full build-out. From its start in 2002 as a contract drug manufacturer, Amneal has grown dramatically to its current position as the 7th largest US generics supplier by volume.

Our new Ireland facility is critical to Amneal’s long-term global growth, in Europe, the US and throughout the world,” Chintu Patel, Amneal co-CEO and co-chairman

IDA Ireland chief executive Martin Shanahan said regional development is a core part of the agency’s strategy.

“This announcement is great news for Tipperary and the whole of the South East region. That Amneal has chosen to locate in a facility that had been occupied previously is especially pleasing” 

Martin Shanahan, Chief Executive, IDA Ireland

Tags : , ,

Share:

Subscribe to Newsletter